Skip to content

Clinical and mechanism of Tuihong Formula in the Treatment of mild to moderate atopic dermatitis

Clinical and mechanism of Tuihong Formula in the Treatment of mild to moderate atopic dermatitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000398
Enrollment
Unknown
Registered
2026-02-13
Start date
2025-02-25
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Interventions

Sponsors

Guangzhou Dermatology Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1).Age = 12 years; (2).The clinical diagnosis of atopic dermatitis is that the disease severity meets the criteria of mild (<=7 points) and moderate (7 to <=21 points) according to the Eczema Area and Severity Index (EASI). (3).The last use of topical drug was at least 3 days before study entry; (4).The patient was informed and signed the consent form.

Exclusion criteria

Exclusion criteria: (1).For patients with severe and extensive skin lesions, topical medications alone may be difficult to control the condition and systemic treatment should be considered; (2).Severe skin infection or oozing in the area of ??atopic dermatitis; (3).Patients with other serious primary diseases or systemic diseases (such as heart, liver, kidney, brain, blood and other systemic diseases), as well as mental illness and malignant tumors; (4).Patients with other skin diseases who require combined treatment; (5).Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Eczema area and severity index;

Secondary

MeasureTime frame
The investigator's global assessment;Peak pruritus numeric rating scale;Patient oriented eczema measure;Dermatology life quality index;Stratum Corneum Hydration;Transepidermal Water Loss;Assessment of sleep reduction;

Countries

China

Contacts

Public ContactTie Zhao

Guangzhou Dermatology Hospital

334844882@qq.com86-13466615738

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026